| P50 | author | Robert S. Negrin | Q110528996 |
| P2093 | author name string | Dennis B Leveson-Gower | |
| | Emanuela I Sega | |
| | Richard H Luong | |
| | Janelle A Olson | |
| | Jeanette Baker | |
| | Robert Zeiser | |
| P2860 | cites work | Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells | Q22253977 |
| | Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. | Q33528964 |
| | Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells | Q33715925 |
| | Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers | Q34567309 |
| | Shifting foci of hematopoiesis during reconstitution from single stem cells | Q35122188 |
| | Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets | Q35158939 |
| | In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets | Q35847952 |
| | Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease | Q36357597 |
| | CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. | Q36362981 |
| | Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease | Q36368026 |
| | Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function | Q36371748 |
| | Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells | Q36384673 |
| | Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity | Q36447926 |
| | NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis | Q37102921 |
| | TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors | Q37291642 |
| | Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease | Q37388077 |
| | IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation | Q37484523 |
| | Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. | Q41005207 |
| | Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction | Q41262864 |
| | A role for interleukin-1 alpha in immunologically mediated intestinal pathology | Q41531167 |
| | Recent advances in graft-versus-host disease (GVHD) prevention | Q41561701 |
| | Nitric oxide mediates intestinal pathology in graft-vs.-host disease | Q41609720 |
| | Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease | Q41640832 |
| | Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation | Q43494585 |
| | Host-residual invariant NK T cells attenuate graft-versus-host immunity | Q43515226 |
| | Superagonist CD28 antibody preferentially expanded Foxp3-expressing nTreg cells and prevented graft-versus-host diseases | Q44111698 |
| | Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging | Q44189640 |
| | CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 |
| | Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism | Q46763980 |
| | Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4. | Q53518152 |
| | In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. | Q53589050 |
| | Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. | Q54567155 |
| | Stimulation of Host NKT Cells by Synthetic Glycolipid Regulates Acute Graft-versus-Host Disease by Inducing Th2 Polarization of Donor T Cells | Q63363303 |
| | Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors | Q70466597 |
| | NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion | Q70527039 |
| | Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease | Q71809477 |
| | Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease | Q71870327 |
| | Differential cytokine production associated with distinct phases of murine graft-versus-host reaction | Q72720440 |
| | Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice | Q72776658 |
| | Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways | Q73850509 |
| | Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies | Q74576875 |
| | Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion | Q78488955 |
| | Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission | Q78961005 |
| | Protective conditioning for acute graft-versus-host disease | Q81279975 |
| | [Combination of dexamethasone with IL-2 selectively induces the expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft versus host disease.]. | Q82807806 |
| | Graft-versus-host disease | Q83468020 |
| | Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation | Q84595134 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3220-3229 | |
| P577 | publication date | 2011-01-21 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism | |
| P478 | volume | 117 | |